Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin-Induced Lung Injury

Area of Science:

• Pulmonary Medicine
• Immunology
• Cell Biology

Background:

• Pulmonary fibrosis is a progressive lung disease with few treatments.
• Bleomycin-induced lung injury is a common model for studying pulmonary fibrosis.
• The molecular mechanisms underlying bleomycin-induced lung fibrosis are not fully understood.

Purpose of the Study:

• To investigate the role of oxidized mitochondrial DNA (oxid-mtDNA) in bleomycin-induced lung fibrosis.
• To elucidate the signaling pathways involved in oxid-mtDNA-mediated lung injury.
• To identify potential therapeutic targets for pulmonary fibrosis.

Main Methods:

• Induction of lung injury using bleomycin in mice.
• Analysis of reactive oxygen species (ROS) and oxidative damage.
• Detection and injection of oxid-mtDNA.
• Assessment of neutrophil infiltration and macrophage polarization.
• Studies using STING- and NLRP3-deficient mice.

Main Results:

• Bleomycin treatment caused ROS-mediated oxidative damage and released oxid-mtDNA.
• Oxid-mtDNA promoted inflammation, neutrophil recruitment, and M2 macrophage polarization.
• Direct injection of oxid-mtDNA induced lung fibrosis.
• STING and NLRP3 pathways are critical downstream mediators of oxid-mtDNA signaling.

Conclusions:

• Oxidized mitochondrial DNA is a key mediator linking oxidative stress to immune activation and fibrosis in the lung.
• Targeting oxid-mtDNA and its downstream signaling pathways (STING, NLRP3) may be a viable therapeutic strategy for pulmonary fibrosis.